We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Spire Healthcare Group Plc | LSE:SPI | London | Ordinary Share | GB00BNLPYF73 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.50 | 0.20% | 252.50 | 252.00 | 253.00 | 257.50 | 251.50 | 257.50 | 478,396 | 16:29:09 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Health & Allied Services,nec | 1.36B | 27.3M | 0.0676 | 37.35 | 1.02B |
Date | Subject | Author | Discuss |
---|---|---|---|
18/1/2018 22:56 | NHS crisis helps private healthcare providers | bountyhunter | |
17/1/2018 10:23 | Jeffries has a buy rating and 290p target today | che7win | |
17/1/2018 08:41 | Must be some news to provide the turnaround today? | che7win | |
16/1/2018 12:11 | maybe an agreed offer would count as a 'change of circumstances'? it's a bit vague though so my guess is that we have at least a 4 mths wait from here before we may see a revised offer | bountyhunter | |
16/1/2018 11:47 | Four more months from now, though there is a provision in the Takeover Code for a new offer to be made if there is a 'change in circumstances'.Not sure what qualifies though. | samdb | |
16/1/2018 09:35 | that was my thinking also, not until after 6 months is up following the prior offer rejection though, not checked which date that takes us to | bountyhunter | |
16/1/2018 09:05 | They bought because they know another offer will come and this time they'll accept it | samdb | |
16/1/2018 09:04 | no problem, watching this one closely post recent director purchases, quite volatile at times | bountyhunter | |
16/1/2018 09:01 | bounty hunter, thanks... 'confirms previous guidance for its 2017'... oversight on my part JD2 | jakedog2 | |
16/1/2018 08:38 | jd - "confirms previous guidance for its 2017 financial year issued on 14 September: it expects to report 2017 full year results as follows: -- Revenues in the range of GBP929 million to GBP932 million" nothing vague about that, it's a trading statement stating a narrow range for 2017 revenues in line with previous guidance | bountyhunter | |
16/1/2018 08:35 | As I mentioned recently, very surprised they did not accept the offer. | essentialinvestor | |
16/1/2018 08:33 | 1) Am i missing something.... where does it say in line ? 2) Very vague compared to those previously released in Jan 3) Revenue is a miss IMHO v forecast of 944 4) EBITDA is -8% v last Jan TU | jakedog2 | |
16/1/2018 07:54 | I think a lot of people were expecting more bad news so quite happy with inline. | samdb | |
16/1/2018 07:48 | 2017 trading in line with expectations; results 2 March | bountyhunter | |
15/1/2018 12:25 | Tomorrow or Wednesday I contacted them... | mj19 | |
13/1/2018 11:15 | It's was around 8th Jan last year so it could be anytime.They are also doing a capital markets day Q1, precise date unknown but I know last month they were putting the final touches to that and looking forward to getting their story out there. | che7win | |
13/1/2018 10:31 | When is the trading update this month | mj19 | |
10/1/2018 09:36 | Trending up nicely. | che7win | |
10/1/2018 09:21 | Trading update was 12 Jan last yr..... | jakedog2 | |
05/1/2018 13:24 | well spotted, here's a link to that which also states: "Among 11 analysts covering Spire Healthcare Group (LON:SPI), 5 have Buy rating, 1 Sell and 5 Hold." | bountyhunter | |
05/1/2018 08:33 | JP Morgan with 339p target on these from yesterday. 04 Jan 18 JP Morgan Cazenove Neutral 254.30 339.00 339.00 Reiterates | che7win | |
03/1/2018 20:10 | good point | bountyhunter | |
03/1/2018 18:04 | The nationwide operations being postponed surely will force operations into the likes of SPI? | che7win |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions